Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 28506242)

  • 1. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
    Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
    J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma.
    Shu J; Li L; Sarver AE; Pope EA; Varshney J; Thayanithy V; Spector L; Largaespada DA; Steer CJ; Subramanian S
    Oncotarget; 2016 Apr; 7(16):21298-314. PubMed ID: 26802029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
    Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
    Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
    Sarver AL; Thayanithy V; Scott MC; Cleton-Jansen AM; Hogendoorn PC; Modiano JF; Subramanian S
    Orphanet J Rare Dis; 2013 Jan; 8():7. PubMed ID: 23311495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
    Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
    Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
    Oshima G; Poli EC; Bolt MJ; Chlenski A; Forde M; Jutzy JMS; Biyani N; Posner MC; Pitroda SP; Weichselbaum RR; Khodarev NN
    Cancer Res; 2019 Feb; 79(3):650-662. PubMed ID: 30538122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population.
    Martin-Guerrero I; Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Santos-Zorrozua B; Dolžan V; Patiño-Garcia A; Garcia-Orad A
    Sci Rep; 2018 Oct; 8(1):15414. PubMed ID: 30337581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
    Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
    Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
    Thayanithy V; Sarver AL; Kartha RV; Li L; Angstadt AY; Breen M; Steer CJ; Modiano JF; Subramanian S
    Bone; 2012 Jan; 50(1):171-81. PubMed ID: 22037351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia.
    Manodoro F; Marzec J; Chaplin T; Miraki-Moud F; Moravcsik E; Jovanovic JV; Wang J; Iqbal S; Taussig D; Grimwade D; Gribben JG; Young BD; Debernardi S
    Blood; 2014 Mar; 123(13):2066-74. PubMed ID: 24493669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome.
    Beygo J; Küchler A; Gillessen-Kaesbach G; Albrecht B; Eckle J; Eggermann T; Gellhaus A; Kanber D; Kordaß U; Lüdecke HJ; Purmann S; Rossier E; van de Nes J; van der Werf IM; Wenzel M; Wieczorek D; Horsthemke B; Buiting K
    Eur J Hum Genet; 2017 Aug; 25(8):935-945. PubMed ID: 28635951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel deletions affecting the MEG3-DMR provide further evidence for a hierarchical regulation of imprinting in 14q32.
    Beygo J; Elbracht M; de Groot K; Begemann M; Kanber D; Platzer K; Gillessen-Kaesbach G; Vierzig A; Green A; Heller R; Buiting K; Eggermann T
    Eur J Hum Genet; 2015 Feb; 23(2):180-8. PubMed ID: 24801763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paternal uniparental disomy chromosome 14-like syndrome due a maternal de novo 160 kb deletion at the 14q32.2 region not encompassing the IG- and the MEG3-DMRs: Patient report and genotype-phenotype correlation.
    Corsello G; Salzano E; Vecchio D; Antona V; Grasso M; Malacarne M; Carella M; Palumbo P; Piro E; Giuffrè M
    Am J Med Genet A; 2015 Dec; 167A(12):3130-8. PubMed ID: 26333487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
    Zehavi L; Avraham R; Barzilai A; Bar-Ilan D; Navon R; Sidi Y; Avni D; Leibowitz-Amit R
    Mol Cancer; 2012 Jul; 11():44. PubMed ID: 22747855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
    Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
    Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.
    Haller F; von Heydebreck A; Zhang JD; Gunawan B; Langer C; Ramadori G; Wiemann S; Sahin O
    J Pathol; 2010 Jan; 220(1):71-86. PubMed ID: 19768731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.
    Gougelet A; Pissaloux D; Besse A; Perez J; Duc A; Dutour A; Blay JY; Alberti L
    Int J Cancer; 2011 Aug; 129(3):680-90. PubMed ID: 20949564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprinting defects in osteosarcoma: DNA- and chromatin-modifying drugs hold promise for osteosarcoma therapy.
    Sarver AE; Subramanian S
    Epigenomics; 2016 Jul; 8(7):885-8. PubMed ID: 27366930
    [No Abstract]   [Full Text] [Related]  

  • 19. Male-specific coordinated changes in expression of miRNA genes, but not other genes within the DLK1-DIO3 locus in multiple sclerosis.
    Baulina N; Kiselev I; Kozin M; Kabaeva A; Boyko A; Favorova O
    Gene; 2022 Aug; 836():146676. PubMed ID: 35714798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
    Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
    Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.